Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit

Samankaltaisia teoksia

• Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
  Tekijä: Chierakul, W, et al.
  Julkaistu: (2005)
• Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
  Tekijä: Cheng, A, et al.
  Julkaistu: (2009)
• Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.
  Tekijä: Chetchotisakd, P, et al.
  Julkaistu: (2014)
• Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
  Tekijä: Chaowagul, W, et al.
  Julkaistu: (2005)
• Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial
  Tekijä: Chetchotisakd, P, et al.
  Julkaistu: (2014)